Progyny (NASDAQ:PGNY) PT Lowered to $22.00

Progyny (NASDAQ:PGNY – Get Free Report) had its target price decreased by analysts at JPMorgan Chase & Co. from $31.00 to $22.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of […]

Leave a Reply

Your email address will not be published.

Previous post Oncolytics Biotech (NASDAQ:ONCY) Rating Reiterated by HC Wainwright
Next post The Goldman Sachs Group Initiates Coverage on Wyndham Hotels & Resorts (NYSE:WH)